Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Cristina Borrachero-Garro"'
Autor:
Juan González-Moreno, Álvaro Gragera-Martínez, Adrián Rodríguez, Cristina Borrachero-Garro, Sandra García-Garrido, Carles Barceló, Ana Manovel-Sánchez, Maria Antonia Ribot-Sansó, Lesly Ibargüen-González, Rosa Gomila, Francisco Muñoz-Beamud, Inés Losada-López, Eugenia Cisneros-Barroso
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Early identification of ATTRv amyloidosis disease onset is still often delayed due to the lack of validated biomarkers of this disease. Light chain neurofilament (NfL) have shown promising results in early diagnosis in this disease, but data
Externí odkaz:
https://doaj.org/article/f491e56deaff4e268c5c6c466f3a8c66
Autor:
Loreto, Domínguez Senín, Cristina, Borrachero Garro, Ernesto, Sánchez Gómez, María Dolores, Santos-Rubio
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 60:311-316
Hereditary transthyretin amyloidosis (hATTR) is an ultra-rare illness. Inotersen is a 2'-O-methoxyethyl (2'MOE)-modified antisense oligonucleotides (ASO) approved in 2018 as a polyneuropathy treatment for adults with hereditary transthyretin amyloido
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a126d7660320428a0dcc8b32854ba5a9
https://doi.org/10.5414/cp204190
https://doi.org/10.5414/cp204190